……
Posaconazole 泊沙康唑 , بوساكونازول , Позаконазол
Sch
–56592
4-[4-[4-[4-[[(5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one
- Noxafil
- SCH 56592
-
Melting Point
-
170-172 deg CO’Neil, M.J. (ed.). The Merck Index – An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 1365
-
Solubility
-
In water, 0.027 mg/L at 25 deg C (est)US EPA; Estimation Program Interface (EPI) Suite. Ver.3.12. Nov 30, 2004. Available from, as of Dec 19, 2005:http://www.epa.gov/oppt/exposure/pubs/episuitedl.htm
1H NMR PREDICT
13C NMR PREDICT
COSY PREDICT
CN101824009A * | May 27, 2010 | Sep 8, 2010 | 北京德众万全药物技术开发有限公司 | Simple preparation method for posaconazole and piperazine intermediate thereof |
Citing Patent | Filing date | Publication date | Applicant | Title |
---|---|---|---|---|
WO2015011224A1 * | Jul 24, 2014 | Jan 29, 2015 | Sandoz Ag | Improved process for the preparation of crystalline form iv of posaconazole |
/////
सुकून उतना ही देना प्रभू, जितने से जिंदगी चल जाये। औकात बस इतनी देना, कि औरों का भला हो जाये।
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO …..FOR BLOG HOME CLICK HERE
Join me on Facebook FACEBOOK
amcrasto@gmail.com


जिंदगी चल जाये।
औकात बस इतनी देना,
कि औरों का भला हो जाये।